PMID- 28196239
OWN - NLM
STAT- MEDLINE
DCOM- 20170222
LR  - 20170622
IS  - 1538-3598 (Electronic)
IS  - 0098-7484 (Linking)
VI  - 317
IP  - 6
DP  - 2017 Feb 14
TI  - Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient
      for Long-term Benefit?
PG  - 591-593
LID - 10.1001/jama.2017.0128 [doi]
FAU - Cox, Linda S
AU  - Cox LS
AD  - University of Miami Miller School of Medicine at Holy Cross Hospital, Ft
      Lauderdale, Florida.
LA  - eng
PT  - Journal Article
PT  - Comment
PL  - United States
TA  - JAMA
JT  - JAMA
JID - 7501160
RN  - 0 (Allergens)
SB  - AIM
SB  - IM
CON - JAMA. 2017 Feb 14;317(6):615-625. PMID: 28196255
EIN - JAMA. 2017 Mar 21;317(11):1179. PMID: 28241213
MH  - Administration, Sublingual
MH  - Allergens/administration & dosage
MH  - Desensitization, Immunologic
MH  - Humans
MH  - Immunotherapy
MH  - Rhinitis, Allergic/*therapy
MH  - Rhinitis, Allergic, Perennial/drug therapy
MH  - *Sublingual Immunotherapy
MH  - Treatment Outcome
EDAT- 2017/02/15 06:00
MHDA- 2017/02/23 06:00
CRDT- 2017/02/15 06:00
PHST- 2017/02/15 06:00 [entrez]
PHST- 2017/02/15 06:00 [pubmed]
PHST- 2017/02/23 06:00 [medline]
AID - 2601485 [pii]
AID - 10.1001/jama.2017.0128 [doi]
PST - ppublish
SO  - JAMA. 2017 Feb 14;317(6):591-593. doi: 10.1001/jama.2017.0128.